Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine

Cladribine has been approved for the treatment of multiple sclerosis (MS) and its administration results in a long-lasting depletion of lymphocytes. As lymphopenia is known to hamper immune responses to vaccination, we evaluated the immunogenicity of the influenza vaccine in patients undergoing clad...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolfes, Leoni, Pfeuffer, Steffen, Skuljec, Jelena, He, Xia, Su, Chuanxin, Oezalp, Sinem-Hilal, Pawlitzki, Marc, Ruck, Tobias, Korsen, Melanie, Kleinschnitz, Konstanze, Aslan, Derya, Hagenacker, Tim, Kleinschnitz, Christoph, Meuth, Sven G., Pul, Refik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177067/
https://www.ncbi.nlm.nih.gov/pubmed/37174643
http://dx.doi.org/10.3390/cells12091243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177067/
https://www.ncbi.nlm.nih.gov/pubmed/37174643
http://dx.doi.org/10.3390/cells12091243

Ejemplares similares